Literature DB >> 22440677

Network meta-analysis of margin threshold for women with ductal carcinoma in situ.

Shi-Yi Wang1, Haitao Chu, Tatyana Shamliyan, Hawre Jalal, Karen M Kuntz, Robert L Kane, Beth A Virnig.   

Abstract

BACKGROUND: Negative margins are associated with reduced risk of ipsilateral breast tumor recurrence (IBTR) for women with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS). However, there is no consensus about the best minimum margin width.
METHODS: We searched the PubMed database for studies of DCIS published in English between January 1970 and July 2010 and examined the relationship between IBTR and margin status after BCS for DCIS. Women with DCIS were stratified into two groups, BCS with or without radiotherapy. We used frequentist and Bayesian approaches to estimate the odds ratios (OR) of IBTR for groups with negative margins and positive margins. We further examined specific margin thresholds using mixed treatment comparisons and meta-regression techniques. All statistical tests were two-sided.
RESULTS: We identified 21 studies published in 24 articles. A total of 1066 IBTR events occurred in 7564 patients, including BCS alone (565 IBTR events in 3098 patients) and BCS with radiotherapy (501 IBTR events in 4466 patients). Compared with positive margins, negative margins were associated with reduced risk of IBTR in patients with radiotherapy (OR = 0.46, 95% credible interval [CrI] = 0.35 to 0.59), and in patients without radiotherapy (OR = 0.34, 95% CrI = 0.24 to 0.47). Compared with patients with positive margins, the risk of IBTR for patients with negative margins was smaller (negative margin >0 mm, OR = 0.45, 95% CrI = 0.38 to 0.53; >2 mm, OR = 0.38, 95% CrI = 0.28 to 0.51; >5 mm, OR = 0.55, 95% CrI = 0.15 to 1.30; and >10 mm, OR = 0.17, 95% CrI = 0.12 to 0.24). Compared with a negative margin greater than 2 mm, a negative margin of at least 10 mm was associated with a lower risk of IBTR (OR = 0.46, 95% CrI = 0.29 to 0.69). We found a probability of .96 that a negative margin threshold greater than 10 mm is the best option compared with other margin thresholds.
CONCLUSIONS: Negative surgical margins should be obtained for DCIS patients after BCS regardless of radiotherapy. Within cosmetic constraint, surgeons should attempt to achieve negative margins as wide as possible in their first attempt. More studies are needed to understand whether margin thresholds greater than 10 mm are warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22440677      PMCID: PMC3916966          DOI: 10.1093/jnci/djs142

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  55 in total

1.  Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.

Authors:  Heather R MacDonald; Melvin J Silverstein; Helen Mabry; Brenda Moorthy; Wei Ye; Melinda S Epstein; Dennis Holmes; Howard Silberman; Michael Lagios
Journal:  Am J Surg       Date:  2005-10       Impact factor: 2.565

2.  Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.

Authors:  E B Fish; J A Chapman; N A Miller; M A Link; E Fishell; B Wright; D R McCready; G Y Hiraki; T M Ross; W M Hanna; H L Lickley
Journal:  Ann Surg Oncol       Date:  1998-12       Impact factor: 5.344

3.  Quantitative synthesis in systematic reviews.

Authors:  J Lau; J P Ioannidis; C H Schmid
Journal:  Ann Intern Med       Date:  1997-11-01       Impact factor: 25.391

4.  Indirect comparisons of competing interventions.

Authors:  A M Glenny; D G Altman; F Song; C Sakarovitch; J J Deeks; R D'Amico; M Bradburn; A J Eastwood
Journal:  Health Technol Assess       Date:  2005-07       Impact factor: 4.014

5.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

Authors:  E R Fisher; J Dignam; E Tan-Chiu; J Costantino; B Fisher; S Paik; N Wolmark
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

6.  Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.

Authors:  Lawrence J Solin; Alain Fourquet; Frank A Vicini; Marie Taylor; Ivo A Olivotto; Bruce Haffty; Eric A Strom; Lori J Pierce; Lawrence B Marks; Harry Bartelink; Marsha D McNeese; Anuja Jhingran; Elaine Wai; Nina Bijker; Francois Campana; Wei-Ting Hwang
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

7.  Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.

Authors:  Sunati Sahoo; Wendy M Recant; Nora Jaskowiak; Liping Tong; Ruth Heimann
Journal:  Breast J       Date:  2005 Jul-Aug       Impact factor: 2.431

8.  Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

Authors:  Bruno Cutuli; Christine Cohen-Solal-le Nir; Brigitte de Lafontan; Hervé Mignotte; Virginie Fichet; Renaud Fay; Véronique Servent; Sylvia Giard; Claire Charra-Brunaud; Claire Lemanski; Hugues Auvray; Stéphane Jacquot; Jean-Christophe Charpentier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

9.  Prospective study of wide excision alone for ductal carcinoma in situ of the breast.

Authors:  Julia S Wong; Carolyn M Kaelin; Susan L Troyan; Michele A Gadd; Rebecca Gelman; Susan C Lester; Stuart J Schnitt; Dennis C Sgroi; Barbara J Silver; Jay R Harris; Barbara L Smith
Journal:  J Clin Oncol       Date:  2006-02-06       Impact factor: 44.544

Review 10.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Authors:  Deborah M Caldwell; A E Ades; J P T Higgins
Journal:  BMJ       Date:  2005-10-15
View more
  33 in total

1.  Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

Authors:  Petrelli Fausto; Sandro Barni
Journal:  Gland Surg       Date:  2012-05

2.  Accelerated partial breast irradiation through brachytherapy for ductal carcinoma in situ: factors influencing utilization and risks of second breast tumors.

Authors:  Ying Liu; Derek T Schloemann; Min Lian; Graham A Colditz
Journal:  Breast Cancer Res Treat       Date:  2015-04-19       Impact factor: 4.872

3.  [Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines].

Authors:  A Lebeau; H Kreipe; M Dietel; W Schlake; R Kreienberg
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

4.  Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey.

Authors:  M T van Mackelenbergh; C M Lindner; T Heilmann; I Alkatout; M Elessawy; C Mundhenke; N Maass; C Schem
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-01       Impact factor: 2.915

5.  Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.

Authors:  Audree B Tadros; Benjamin D Smith; Yu Shen; Heather Lin; Savitri Krishnamurthy; Anthony Lucci; Carlos H Barcenas; Rosa F Hwang; Gaiane Rauch; Lumarie Santiago; Eric A Strom; Sarah M DeSnyder; Wei T Yang; Dalliah M Black; Constance T Albarracin; Mariana Chavez-MacGregor; Kelly K Hunt; Henry M Kuerer
Journal:  Ann Surg       Date:  2019-01       Impact factor: 12.969

6.  Network meta-analysis of randomized clinical trials: reporting the proper summaries.

Authors:  Jing Zhang; Bradley P Carlin; James D Neaton; Guoxing G Soon; Lei Nie; Robert Kane; Beth A Virnig; Haitao Chu
Journal:  Clin Trials       Date:  2013-10-03       Impact factor: 2.486

Review 7.  The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Authors:  M Luke Marinovich; Lamiae Azizi; Petra Macaskill; Les Irwig; Monica Morrow; Lawrence J Solin; Nehmat Houssami
Journal:  Ann Surg Oncol       Date:  2016-08-15       Impact factor: 5.344

8.  Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?

Authors:  Devon Livingston-Rosanoff; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb; Lee G Wilke
Journal:  Breast Cancer Res Treat       Date:  2021-06-15       Impact factor: 4.872

9.  Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.

Authors:  Kimberly J Van Zee; Preeti Subhedar; Cristina Olcese; Sujata Patil; Monica Morrow
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

10.  Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels.

Authors:  Libo Yang; Dongli Lu; Yutian Lai; Mengjia Shen; Qiuxiao Yu; Ting Lei; Tianjie Pu; Hong Bu
Journal:  Ann Surg Oncol       Date:  2020-08-13       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.